FDA Threatens Refusal of Imports from Canadian Fish Processor
The Food and Drug Administration may place products from Canadian seafood processor Sambro Fisheries on detention without physical examination, effectively refusing imports from the company for violations of seafood Hazard Analysis and Critical Control Point regulations, it said in a…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
warning letter. The company’s HACCP plan doesn’t list hazardous allergens for its tuna, marlin, and mahi-mahi, nor does it define a critical control point of refrigerated storage to control scombrotoxin formation. If the company doesn’t respond in 15 days from receipt of the letter, or FDA deems its response inadequate, FDA may refuse admission.